Clinical Trial Update: Validation of Clara Cell Protein as a Novel Diagnostic Biomarker for the Differentiation of Cardiogenic Pulmonary Edema From Non-Cardiogenic Pulmonary Edema

View source ↗

Summary

A completed clinical trial validating Clara Cell Protein as a diagnostic biomarker to differentiate cardiogenic pulmonary edema from non-cardiogenic pulmonary e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Pulmonary Edema
• Non-cardiogenic Pulmonary Edema

Snippet

Sponsor: Beni-Suef University | Conditions: Clara Cell Protein, Diagnostic Biomarker | Status: COMPLETED